INFECTIOUS DISEASES
Comprehensive disease testing
Through BioPharma Diagnostics, our partners have access to Mayo Clinic Laboratories’ infectious disease test catalog, including testing for:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Helicobacter pylori
- Infectious disease pathology
- Vector-borne diseases
- HIV and hepatitis
Our molecular testing methods include:
- Polymerase chain reaction (PCR) testing
- Advanced whole genome microbial sequencing
- Targeted metagenomic sequencing
- Matrix-assisted laser-desorption/ionization-time of flight (MALDI-TOF) mass spectrometry organism identification
In addition to using clinically available testing, BioPharma Diagnostics partners can access infectious disease testing for clinical trials and be among the first to use up-and-coming tests currently in development.
News and updates
The latest
William Morice II, M.D., Ph.D., recently joined the Advisory Board for a webinar discussion on 2024 lab market trends. Dr. Morice covered the current lab market outlook, the priority trends, and opportunities for future growth.
Blacklegged ticks (also known as deer ticks) are turning up more frequently in Minnesota, and so are the diseases they carry. Bobbi Pritt, a parasitologist in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, weighs in on the issue.
Joseph Yao, M.D., gives an overview of this new test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be taken due to the results of this testing.
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss diagnostic testing options for patients with suspected neuroinvasive Lyme disease or Lyme neuroborreliosis.
In this month’s “Hot Topic,” Elitza Theel, Ph.D. will discuss a new interferon-gamma release assay that can assist in the detection of individuals that are infected with tuberculosis.
In the war against microbes, human beings are vastly outnumbered—and losing the weapons race.
To help you learn more about Lyme disease, “The ABCs of Lyme Disease” flash cards include information about symptoms, treatment, and other important facts.
Teamwork is critical among staff from Mayo Clinic, the Centers for Disease Control and Prevention, Minnesota Department of Health, and the University of Wisconsin-Madison in order to keep tabs on tick trends and defend against vector-borne diseases.
Bobbi Pritt, M.D., a Mayo Clinic parasitic diseases expert, says, as the last of the winter's snow melts, ticks start coming up from under the grass looking for a "blood meal." She says that this year, after a relatively mild winter, ticks got an early start. This means that tick season could be particularly busy. In this "Mayo Clinic Minute," Dr. Pritt explains an easy trick to remember the best ways to protect yourself from tick bites.
With tick season underway in parts of the United States, it's important to understand the signs and symptoms of Lyme disease to determine when to seek medical treatment. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory in Mayo Clinic’s Department of Laboratory Medicine and Pathology, identifies Lyme disease signs and symptoms at AccuWeather.com.
Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory in Mayo Clinic’s Department of Laboratory Medicine and Pathology, discussed how to safety remove ticks from skin with AccuWeather.com.
In this “Hot Topic,” Bobbi Pritt, M.D., discusses how Lyme disease is the most common vector-borne illness in the United States and Europe and caused primarily by Borrelia burgdorferi in the United States, while B burgdorferi, B afzelii, and B garinii cause Lyme disease in Europe. We will also discuss using PCR and melting curve analysis to identify a new species of Borrelia.
In this “Hot Topic,” Elitza Theel, Ph.D., discusses how common cases of presumed Lyme disease go unreported each year and discusses scenarios in which testing for Lyme disease is indicated and reviews both recommended and inappropriate testing methodologies. The overall focus is on performance of the CDC endorsed two-tiered serologic testing algorithm and the latest CDC recommendations.